Detalhe da pesquisa
1.
Neutrophils differentially attenuate immune response to Aspergillus infection through complement receptor 3 and induction of myeloperoxidase.
Cell Microbiol
; 20(3)2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29088499
2.
Tissue penetration of antifungal agents.
Clin Microbiol Rev
; 27(1): 68-88, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24396137
3.
An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity.
J Antimicrob Chemother
; 68(7): 1655-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23557927
4.
Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis.
J Clin Microbiol
; 50(7): 2330-6, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22553232
5.
Observational study of the clinical efficacy of voriconazole and its relationship to plasma concentrations in patients.
Antimicrob Agents Chemother
; 55(10): 4782-8, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21768513
6.
Early proinflammatory cytokines and Creactive protein trends as predictors of outcome in invasive Aspergillosis.
J Infect Dis
; 202(9): 1454-62, 2010 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20879853
7.
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients.
J Antimicrob Chemother
; 65(1): 107-13, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19933691
8.
Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients.
Clin Infect Dis
; 49(10): 1486-91, 2009 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19827955
9.
Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.
Clin Infect Dis
; 44(3): 373-9, 2007 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17205443
10.
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
N Engl J Med
; 347(6): 408-15, 2002 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-12167683
11.
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.
PLoS One
; 9(2): e90176, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24587262
12.
Safety of voriconazole and dose individualization.
Clin Infect Dis
; 36(8): 1087-8, 2003 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12684928